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Abstract
Background: To describe the methodology of the Sankara Nethralaya Diabetic Retinopathy Epidemiology and
Molecular Genetic Study III, an ongoing epidemiological study to estimate the prevalence of Diabetes and Diabetic
Retinopathy in rural population of Kanchipuram and Thiravallur districts of Tamil Nadu, India and to elucidate the
clinical, anthropometric, biochemical and genetic risk factors associated with diabetic retinopathy in this rural
population.
Methods: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study III will be a mobile
van based epidemiological study; 11,760 participants aged ≥ 40 years will be recruited from the study areas.
Eligible subjects will undergo blood sugar estimation to diagnose Diabetes. Oral Glucose Tolerance Test will be
done to conform diabetes. All subjects with diabetes will undergo complete information of knowledge, aptitude
and practice of diabetes and diabetic retinopathy, Diet questionnaire, demographic data, socioeconomic status,
physical activity, anthropometric measurements, and risk of sleep apnoea. A detailed medical and ocular history, a
comprehensive eye examination including refraction, slit lamp biomicroscopy examination, indirect
ophthalmoscopy, slit lamp biomicroscopy, digital stereo fundus photography and ultrasound of eye will be done in
the mobile van. Blood will be collected for biochemical investigations including blood hemoglobin, glycosylated
hemoglobin, lipid profile, urea and creatinine, genetic study. Urine will be collected for microalbuminuria. All
fundus photographs will be graded at base hospital. Participants who need treatment will be sent to the base
hospital. A computerized database is created for the records.
Conclusion: The study is expected to provide an estimate of the prevalence of Diabetes and Diabetic Retinopathy
and also a better understanding of the genetic, anthropometric and socio-economic risk factors associated with
Diabetic Retinopathy in a Rural South Indian population.
Background
The number of adults with diabetes in the world is esti-
mated to increase by 122%(135 million in 1995 to 300
in 2025).This increase is expected to be 42% in the
developed world and 170% in the developing countries.
India stands first with 195% (18 million in 1995 to
54 million in 2025) [1]. Diabetes mellitus was considered
as an urban disease previously, however recent studies
clearly shown increasing prevalence in rural areas as
well [2-4]. Indian studies shows three fold increase in
rural prevalence of diabetic in last one and half decade
(2.2% in 1989 to 6.3% in 2003) [3]. In a cross sectional
study of self reported population attending diabetic reti-
nopathy screening camps it is found the rural prevalence
of diabetes as 20% [4].
Diabetic retinopathy has been one of the foremost
causes of blindness in the working age group of both
developed and developing countries [1]. In India it is
the 6
th cause of blindness at present which is increasing * Correspondence: drts@snmail.org
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valence of diabetic retinopathy also increasing [5].
Our previous report shows the prevalence of Diabetic
retinopathy between rural and urban diabetic attending
diabetic retinopathy screening camps which showed age
adjusted prevalence of DR is 18% among both rural and
urban diabetics [4].
Currently there are no population-based studies,
which studied exclusively prevalence of diabetic retino-
pathy in rural area.
The present population-based study has been designed
to answer the following questions:
1. What is the prevalence of diabetes mellitus in a
rural south India population of, Tamil Nadu, India?
2. What is the prevalence of diabetic retinopathy in
this well-defined population of diabetics, both newly
diagnosed and previously diagnosed?
3. What are the risk factors–clinical, socio demo-
graphic, anthropomorphic, and biochemical–associated
with diabetic retinopathy?
4. What sequence variants or polymorphisms in the
RAGE, VEGF, PKC-b, and ApoE genes are asso-
ciated with diabetic retinopathy?
This paper describes the study design and research
methodology for SN-DREAMS-III
Methods/Design
The study procedure is divided into five steps
Step I: Epidemiological field work
Step II: Training program, quality control, pilot study,
definitions
Step III: Medical history questionnaire
Step IV: Ophthalmic examination, fundus photogra-
phy, diabetic retinopathy classification
Step V: Biochemical investigations and genetic study
Step I: Epidemiological Field work
This is an ongoing population-based cross-sectional
study which commenced in June 2007, and data collec-
tion is likely to be completed by March 2010. The study
has been approved by the Institutional Review Board of
Sankara Nethralaya (Vision Research Foundation),
Chennai, India.
a) Sample Size Estimation
Till now there are no true estimates of diabetic retino-
pathy among the rural population in India. Hence for
the sample calculation we are using the best estimates
that are available in literature. After analyzing various
related studies, assuming a 2% prevalence of diabetic
retinopathy among the rural population above the age
of 40 yrs, the estimated sample size was 11760; keeping
a design effect of 2 with precision of 80% and compli-
ance of 80%.
b) Study Area
We have selected rural area of Kanchipuram and Thira-
vallur district of Tamilnadu, for conveniences. Each
rural district has 8 talukas and 1,655 villages. We have
randomly selected 26 villages, which are divided into 26
clusters, 13 from each of the districts. The definition of
rural areas includes population of less than 5,000, popu-
lation density of less than 400/square kilometre, and at
least 25% of male population engaged in agricultural
activities; a similar definition is adopted by the National
Banks of India. The Demographic Data of the Study
Areas is described in table 1
C) Sampling Method
A multi-stage cluster sampling method will be used in
the study. A cluster will be defined as having a popula-
tion of 1,200-2,000, and if the population of any village
is found to exceed this number, the population is
divided into 2 or more clusters.
d) Eligibility and exclusion criteria
People aged 40 years and above or those turning 40 in
the current calendar year and resident at the target
address for a minimum period of six months are
included in the study. People staying at the target
households for a period of less than six months, tempor-
ary residents (people who have permanent residence
elsewhere), a resident who passes away after the enu-
meration but prior to examination, and an eligible resi-
dent who cannot be contacted after five physical
attempts by the social worker are excluded from the
study. Individuals who cannot be transported to the
examination centre due to health reasons are excluded
from the study.
e) Mapping and listing
A proper mapping and listing of the households is being
done in a systematic manner to avoid omissions or




Male 1457242 50.64 1397407 50.73
Female 1420226 49.36 1357349 49.27
Literacy Rate 1952198 67.84 1867707 67.80
% Population ≥ 40 years 776871 26.99 716737 26.02
Religion
Hindu 2583590 89.79 2476438 89.90
Muslim 113666 3.95 99408 3.61
Christian 170416 5.92 169719 6.16
Others 831 0.03 5713 0.21
Religion not stated 3679 0.13 3478 0.13
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tures of the study area is being prepared, and all houses
are numbered serially.
f) Household enumeration
Family members living on the same premises and sharing
a common kitchen are defined as one household.
A door-to-door survey of all the households on both
sides of the street is conducted in the selected villages till
we enumerate the calculated sample size. The household
data sheet contains details of demography, educational
qualification, occupation, residential status, and ocular
and systemic disease, if any.
g) Appointments
Eligible subjects will be given an appointment date for
an eye examination to be conducted in a mobile van,
which is stationed at a convenient place. The mobile
van has been designed to include all equipment that is
necessary for the studies. All patients will be examined
in the mobile van. The patients who need treatment are
transported to the base hospital on an appointed date.
h) Refusals
A refusal will be recorded when the occupants of the
household refuse to provide any information or refuse
to comply with the examination even on repeated
requests. A maximum of five attempts will be made to
convince them to attend the study; if unsuccessful, they
will be considered as dropouts.
i) Estimation of Fasting Blood Glucose
The team will visit the selected households a day in
advance to request eligible individuals to observe a
minimum of 8 hours of overnight fasting prior to esti-
mation of the fasting capillary blood glucose levels the
next morning. Using Accutrend Alpha, blood glucose
estimation will be done on a sample of capillary blood
obtained by finger-prick (Glucose Oxidase method). In
accordance with the ADA criteria [6], subject with
newly-detected diabetes is defined as the one having a
fasting blood glucose ≥110 mg/dl. For patients who for-
get the fasting instructions and for dropouts, the fasting
blood glucose will be estimated on Sundays or at their
convenience.
Step II: Training Program, Quality Control, Pilot Study,
Definitions
a)Training Program
T h ee p i d e m i o l o g yt e a mo fS a n k a r aN e t h r a l a y ap r o v i d e d
intensive training on a one-to-one basis to all the team
members. This lasted for 7 days with 8 hours a day of
training sessions. The aim was to ensure that each
member of the team was well trained in doing a house-
hold survey, enumeration, and filling out the study data
sheet. The trainees were instructed to use the sphygmo-
manometers and glucometer for estimating blood pres-
sure and capillary blood glucose. The main objective
was to avoid bias or errors in any of the procedures
employed. Each trainee was evaluated individually and
allowed to participate in the study only after he or she
displayed minimum error rates for the tasks involved in
the study.
b) Quality Control
In order to ensure accurate and reliable data, a compre-
hensive instruction manual has been prepared. A start-
up training session helped us to standardize all the
examination and diagnostic procedures. The glucometer
is calibrated every day and its reproducibility is assessed
by measuring the blood glucose for the same patient six
times and also with two machines. A similar procedure
is undertaken for the sphygmomanometer. The scale for
measuring the weight is calibrated with a known weight
once a week. The collected data is scrutinized manually
before its entry into the computer.
c) Pilot Study
A pilot study was conducted taking 480 patients from
the first village (Pyrarithangal); this was done to identify
the initial practical difficulties in carrying out the study.
The first step was the selection of the participants. Next,
informed consent was obtained after the study had been
explained to each participant and the interviewer was
certain that the participant understood and accepted the
contents. The subjects underwent the entire sequence of
examination and laboratory procedures as planned for
the actual study. During the pilot study, inter- and
intraobserver variations for the photographic classifica-
tion of diabetic retinopathy were compared (in order to
minimize bias); kappa was 0.83 and 1.0, respectively.
A Kappa value of > 0.8 suggests good agreement between
the observers. A time-motion study was done to deter-
mine the time needed for a complete examination. The
study revealed that it took 2 hours and 45 minutes for
the collection of all the data, which included medical his-
tory, questionnaires and anthropometric measurements
(45 minutes); ophthalmic work-up (1 hour); dilatation,
fundus examination, and fundus photography (30 min-
utes); vibration perception threshold (VPT) testing and
genetic work-up (30 minutes). The pilot study concluded
that there was no questionnaire fatigue and a good
response rate, creating the necessary confidence to
proceed with the study.
d) Definitions
The various definitions taken in this study are sum-
marised in the table 2
Steps III: History and Examination procedures
a) Medical history and questioner
A detailed questionnaire will be administered regarding
the medical history, a general physical examination,
habitual history and educational and occupation history.
The data in the medical history include duration and
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of diabetes, coronary artery disease, symptoms related to
diabetic nephropathy or neuropathy, the presence of an
ear lobe crease, and duration of total sleep. The ocular
history includes details of the first and last eye examina-
tion, present or past ocular complaints, and laser treat-
ment or ocular surgery. Tobacco and alcohol history
includes duration, type, amount, and age at start, pre-
sent and past status. Occupation and education history
also taken.
b) Ophthalmic examination
I) Visual Acuity and Refraction The modified ETDRS
chart (Light House Low Vision Products, New York,
NY,USA) is used to test the distance visual acuity; and
for those who cannot read the English alphabet, Land-
olt’s ring test is used. If the visual acuity is less than 4/4
(logMAR 0.0), the pinhole visual acuity is assessed.
Objective refraction is performed with a streak retino-
scope (Beta 200, Heine, Germany) followed by subjective
refraction. If the subject is unable to read the 4/40 (log-
MAR 1.0) line, vision is checked at one meter. If he or
she is still unable to identify any of the largest opto-
types, perception of hand movements is observed. If
hand movements cannot be identified, the examiner
checks for perception of light, which is recorded as pre-
sent or absent.
II) External Examination External examination is per-
formed using a handheld flashlight. The face and eyes
are examined for the presence of strabismus, extra
ocular movement abnormalities or any other gross
abnormality.
III) Slit-Lamp Examination The Topcon SL-D7 ( Top-
con corporation, Japan) slitlamp is used. Using a moder-
ately wide beam, the eyelids, margins, lashes, canthi, and
puncta are systematically examined, followed by the pal-
pebral and bulbar conjunctiva, sclera and cornea. Then,
using a narrow parallelopiped beam, the cornea, anterior
chamber and iris are examined for abnormality. Grading
of peripheral anterior chamber depth is done according
to the Van Herick grading.The iris and pupillary mar-
gins are examined under high magnification to look for
iris neovascularization.
IV) Applanation Tonometry Using the Goldmann
applanation tonometer (Hagg-streit AT 900, Hagg-streit
AG, Switzerland ), the intraocular pressure (IOP) is
measured in both eyes; 0.5% proparacaine eyedrops are
used for topical anesthesia, and a 2% fluorescein strip to
stain the tear film [7].
V) Gonioscopy Gonioscopy is performed in dim ambi-
ent illumination with a shortened slit that does not fall
on the pupil. A Sussmann-type 4-mirror handheld
gonioscope (Volk Optical Inc, Mentor,Ohio,USA) is
used. Gonioscopy is performed only on those patients
who have an elevated intraocular pressure, iris neovas-
cularization or a shallow anterior chamber (Van Her-
rick’s grading ≤ 2). The angle is graded according to the
Shaffer grading; the peripheral iris contours, degree of
trabecular meshwork pigmentation and angle neovascu-
larization are also recorded. In eyes with an occludable
angle, laser iridotomy is performed before dilatation; the
rest of examination is done at a later date [8].
VI) Grading of Lens Opacities The subject’s pupils are
dilated with 5% phenylephrine and 1% tropicamide eye-
drops; if phenylephrine is contraindicated, 1% cyclopento-
late eyedrops are used. Grading of lens opacities is
performed using the Lens Opacities Classification Sys-
tem60 (LOCS chart III, Leo T. Chylack, Harvard Medical
School, Boston, MA). Lenticular opacities are graded by
comparison with the standard set of photographs, which
are retroilluminated by mounting on a light box. With
the slit beam at a 45◦ angle, the slit height and width are
adjusted to approximate the overall brightness of the cor-
neal image and anterior subcapsular zone to nuclear
color/opalescence standard N1; 0◦ brightness is allowed
to visualize all the lens opacities without causing discom-
fort to the patient. Keeping the slit width at 0.2 mm,
nuclear opalescence (NO) and nuclear color (NC) are
graded by comparing the slit-lamp examination image
Table 2 Definitions
Provisional diabetics New asymptomatic individual with a first fasting blood glucose level ≥110 mg/dl (Accutrend alpha)
Known diabetics Diagonosis of diabetes made by a medical practitioner, or patient using hypoglycemic medication,either oral or insulin or
both medication, either oral or insulin or both.
Newly diagnosed
diabetics
Fasting blood glucose level ≥110 mg/dl on two separate days; provisional diabetics were retested at the base hospital by
the laboratory method.
Duration of diabetes Time interval between the date of diagnosis of diabetes (as made by a diabetologist or when the antidiabetic treatment
started) and the date of eye examination.
Hypertension If the systolic BP is ≥140 mm Hg or the diastolic BP is ≥ 90 mm Hg or the patient is on antihypertensive treatment.
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NC6. Cortical cataract (C) and posterior subcapsular cat-
aract (P) are graded by examining the opacity in retroillu-
mination images (0◦ angle) focused either anteriorly (at
the iris plane) or posteriorly (at the plane of the posterior
capsule) and comparing these examination pictures to
the cortical standards C1 to C5 and posterior subcapsular
standards P1 to P5.
VII) Fundus Examination and Clinical Grading The
binocular indirect ophthalmoscope (Keeler Instruments
Inc., Pennsylvania, U.S.A) and +20 D lens (Nikon) are
used to examine the fundus. The macular area is specifi-
cally examined with a +78 D lens (Nikon) to document
any pathology.
VIII) Fundus Photography Considering fundus photo-
graphy is the gold standard, to document and diagnose
diabetic retinopathy, all individual will undergo 45
degree 4 field photograph. The Zeiss, Visucam, fundus
camera with visupac digital image archiving system will
be used to photograph fundus of subjects. Atleast 6 mm
pupil dilatation ( with tropicamide 0.5% and phenylephr-
ine 5%) will be insured before fundus photography. No
image manipulation will be done before or during grad-
ing. Images will be stored as uncompressed jpeg files,
copied to CDs and will be sent for grading. Independent
photo grading of digital fundus photography by retinal
specialist will be done.
Fundus Photography Using Stereo-Pictures Irrespec-
tive of the presence or absence of diabetic retinopathy,
45◦ four-field stereoscopic digital photographs (poster-
ior pole, nasal field, superior and inferior) are taken
for all subjects with a Carl Zeiss fundus camera (Visu-
camlite, Jena, Germany). However, for those who are
found to have diabetic retinopathy on clinical
examination, additional 30◦ seven-field stereodigital
pairs are taken.
IX) Evaluation of Photographic Grading and Quality
T h ep h o t o g r a p h i cg r a d i n ga n dq u a l i t yw i l la s s e s s e d
using the Visupac digital image archiving system. The
“Screenscope” (Berezin Stereo Photography Products,
Mission Viejo, CA, USA), a stereo viewer that can be
fixed on a computer monitor, is used to examine the
stereo pairs. Photographs of each eye are reviewed and
given grades for overall quality. Field definition and
i m a g ec l a r i t ya r eg r a d e da si n a d e q u a t ef o rr e a d i n go r
grading, adequate (sufficient visualization of disc,
macula, and vessels to grade), and good (small vessels or
retinal details visible across 90% of the image) [9].
x) Photographic Grading of Diabetic Retinopathy The
modified classification of diabetic retinopathy based on
the degrees of retinopathy used by Klein et al [10]
(Table 3) is used; digital photographs are assessed and
graded by three independent observers (experienced ret-
inal specialists) in a masked fashion.
Step V: Biochemical Investigations In case of patients
with provisional diabetes, confirmation will be done by
re-estimation of the fasting blood glucose by enzymatic
assay Biochemical analysis is done on the Merck Micro
Lab 120 semi-automated analyzer. Total serum choles-
terol (CHOD-POD method), high-density lipoproteins
(CHOD-POD method after protein precipitation), serum
triglycerides (CHOD-POD), hemoglobin (calorimetric
hemoglobinometer), packed cell volume (capillary
method) and the lycosylated hemoglobin fraction (Bio-
Rad DiaSTAT HbA1c Reagent Kit) will be estimated.
Microalbuminuria estimation will be done by a semi-
quantitative procedure (Clintek 50 Bayer Urine Analy-
zer) with the first morning urine sample.
Table 3 Classification of diabetic retinopathy
Level Definition
1 No retinopathy
1.5 Retinal hemorrhages only, no microaneurysms
2 Micro aneurysms (1 or more) only
3 Micro aneurysms and 1 or more of the following: retinal hemorrhages, but total of hemorrhages and microaneurysms (H/MA) less than
standard (STD) photograph 2A, hard exudates (HE) less than STD photograph 3, soft exudates (SE) questionably present; intraretinal
microvascular (IRMA) abnormalities questionably present; venous beading (VB) questionably present; or small venous loops definitely present
4 Micro aneurysms and 1 or more of the following but definition of level 5 not met: H/Ma greater than or equal to STD photograph 2A, HE
greater than or equal to STD photograph 3, SE definitely present, IRMA definitely present, VB definitely present; large venous loops or
reduplication definitely present
–
5 IRMA definitely present in four peripheral fields and greater than or equal to STD photograph 8A in 2 or more fields; or, again in all 4
peripheral fields any three of the following: H/MA greater than or equal to STD photograph 2A in 1 field, SE definitely present in 2 or more
fields, IRMA definitely present in 2 or more fields, or VB definitely present in 2 or more fields.
6 Fibrous proliferation or new vessels on or within 1 disc diameter (DD) of the disc graded less than photograph 10A, new vessels else where
of any extent or pre retinal or vitreous hemorrhage, but level 7 definition not met
7 Diabetic Retinopathy Study (DRS) high-risk characteristics include one or more of the following: new vessels elsewhere greater than one-half
disc area in any single photographic field and pre retinal hemorrhage or vitreous hemorrhage in any field; new vessels on or within 1 DD of
the disc graded less than photograph 10A with pre retinal or vitreous hemorrhage; new vessels on or within 1 DD of the disc graded greater
than or equal to photograph 10A with or without pre retinal or vitreous hemorrhage.
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Genome-wide association studies are a promising new
tool for deciphering the genetics of complex diseases.
SN-DREAMS III would identify the possible candidate
genes through a whole genome association study in the
south Indian population. Subgroup of type 2 diabetic
patients of ≥ 10 years duration with sight threatening dia-
betic retinopathy will be taken as case and type 2 diabetic
patients of ≥ 15 years duration, without diabetic retinopa-
thy will be taken as control. After obtaining their
informed consent, genomic DNA will be isolated.
Genotypes for each study subjects will be done on the
Affymetrix platform. The outcome will generate data that
would allow the understanding of the various genetic fac-
tors that are possibly involved in the disease pathogenesis.
An overview of the methodology is provided in figure. 1.
Data management
T h ed a t ae n t e r e db yt h es o c i a lw o r k e r s ,o p t o m e t r i s t s ,
ophthalmologist, and lab technician will be counter
checked for any deficiencies by their respective collea-
gues. The person responsible for the checking the
details will have to sign at the end of the page of each
                Provisional Diabetics  Known Diabetics     Non Diabetics       (<100mg/dl)             
                                                                                                                                                
                                                                                                                                        
                                              Oral GTT                                                       EXIT                                      
                                                 
                                                                          
Sample size-11,760 
Rural area of Kanchipuram and 
Thiravallur district 
Epidemiology Field Work 
Enumeration,KAP & Diet (field) Questionnaire 
1st Fasting blood Sugar estimation 




Risk of Sleep Apnoea 
Physical Activity 
Diet  
3. Ophtahlmic examination 
 
Refraction 
Amplitude of accommodation 
Slit Lamp Biomicroscopy 
Indirect Ophthalmoscopy 




Diabetic Retinopathy grading 
2. Physical examination 
 
Blood Pressure 
Resting heart rate 
Body mass index 
Waist hip ratio 
Thigh length 
Neck circumference 
5. Genetic Investigations 
 
 








Vibration perception threshold 
  
 
Figure 1 Pattern of study organization.
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centre, the entire questionnaire will be checked for any
deficiencies. The data from the questionnaire will be
entered in the Microsoft Access. The data willl be dou-
bly entered with limit checks to avoid wrong entries
Data analysis will be conducted using standard statisti-
cal techniques for comparing two independent groups:
chi-squared tests for equality of proportions, indepen-
dent t-test for equality of means, Wilcoxon rank sum
test, multiple logistic and linear regression, and propor-
tional hazards modeling. The distribution of continuous
variables will be assessed by measures of normality and
graphical displays so that non-parametric methods or
data transformations may be applied when appropriate.
Special features of SN-DREAMS III
1) It will be a population based epidemiological study,
so accuracy of data will be much well defined 2) we
have taken a well defined definition of rural population
3)photographic grading for all subject, which is gold
standard. In presence of significant cataract, cataract
surgery followed by fundus photography is being done.
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